Figure 2
From: VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosis
VRK2 and astrocytoma survival. Kaplan-Meier estimates of overall survival in (A) low-grade astrocytomas and (B) high-grade astrocytomas according to VRK2 protein expression. (C). Kaplan-Meier estimates of overall survival for low-risk and high-risk groups, based on the prognostic index combining VRK2 protein level, age and treatment (Table 6) in cases of high-grade astrocytomas.